SCHEMBL23318079

SCHEMBL23318079

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2cccc(-c3nc(-c4ccccc4)nc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)n3)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.49
KDM4E B2RXH2 1/20 0.49
ATM Q13315 1/20 0.49
PTGER4 P35408 1/20 0.41
TSPO P30536 1/20 0.38
AVPR1A P37288 1/20 0.37
PDE10A Q9Y233 1/20 0.37
NPY5R Q15761 1/20 0.36
KMT2A Q03164 4/20 0.36
IL1R1 P14778 1/20 0.36
HDAC4 P56524 1/20 0.36
MEN1 O00255 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 1/20 0.36
ABCG2 Q9UNQ0 2/20 0.35
HTT P42858 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21104271 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL15197832 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL17228040 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL22672092 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL19219020 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL23318119 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL15197744 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24152738 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL23318306 0.99 KDM4E (0.47) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL21113522 0.99 KDM4E (0.47) L3MBTL1KDM4EATMPTGER4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210135118-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210135118-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ELAVL1, EML4, ELAVL3 L3MBTL1 91/4885KDM4E 1670/4885ATM 3651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.